Search Results

1,701 articles with title/keywords/abstract containing Lamivudine

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Content loaded within last 14 days Antiretrovirals: Discoid lupus erythematosus: case report

Source: Reactions, Volume 1, Number 1282, 2009-12-12 , pp. 10-10(1)

Publisher: Adis International

Determination of Lamivudine, Zidovudine, and Nevirapine in Capillary Blood Sampled on Filter Paper by LC

Authors: Malm, M.; Römsing, S.; Obua, C.; Bergqvist, Y.

Source: Journal of Chromatographic Science, Volume 47, Number 10, November/December 2009 , pp. 855-862(8)

Publisher: Preston Publications

Abacavir and lamivudine combination

Authors: Somboonwit, Charurut; Kurtyka, Don; Paula Velez, Ana

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 12, December 2009 , pp. 1599-1606(8)

Publisher: Informa Healthcare

Peginterferon-α-2a (40 kD): A Review of its Use in Chronic Hepatitis B

Author: Keating, Gillian M.

Source: Drugs, Volume 69, Number 18, 24 December 2009 , pp. 2633-2660(28)

Publisher: Adis International

Content loaded within last 14 days Favorable outcome of de novo hepatitis B infection after liver transplantation with lamivudine and adefovir therapy

Authors: Zhang, F.K.; Zhang, Y.; Zhang, J.Y.; Jia, J.D.; Wang, B.E.

Source: Transplant Infectious Disease, Volume 11, Number 6, December 2009 , pp. 549-552(4)

Publisher: Blackwell Publishing

Content loaded within last 14 days A case of acute rejection shortly after initiation of lamivudine therapy in a simultaneous pancreas and kidney recipient with viral hepatitis type B

Authors: Chudek, J.; Kolonko, A.; Ficek, J.; Karkoszka, H.; Baka-Ćwierz, B.; Więcek, A.

Source: Transplant Infectious Disease, Volume 11, Number 6, December 2009 , pp. 553-556(4)

Publisher: Blackwell Publishing

New scoring system for predicting relapse after lamivudine-induced hepatitis B e-antigen loss in chronic hepatitis B patients

Authors: Song, Byung-Cheol; Cui, Xiu Ji; Cho, Yoo-Kyung; Choi, Eun Kwang; Hyun, Soyoung; Song, Hyun Joo; Kim, Heung Up

Source: Hepatology Research, Volume 39, Number 11, November 2009 , pp. 1064-1071(8)

Publisher: Blackwell Publishing

Different models of HBeAg seroconversion predicated by on-treatment ALT and HBV DNA profiles

Authors: You, Hong; Ma, Hong; Liu, Tianhui; Cong, Min; Wang, Ping; Ou, Xiaojuan; Wang, Xiaoming; Ren, Jiangbo; Li, Hongyi; Wang, Baoen; Jia, Jidong

Source: Journal of Viral Hepatitis, Volume 16, Number 12, December 2009 , pp. 876-882(7)

Publisher: Blackwell Publishing

Efavirenz/lamivudine/stavudine: Immune reconstitution syndrome : 2 case reports

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 18-19(2)

Publisher: Adis International

Efavirenz/lamivudine/zidovudine: Immune reconstitution syndrome: case report

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 19-19(1)

Publisher: Adis International

The Cost Effectiveness of Home-Based Provision of Antiretroviral Therapy in Rural Uganda

Authors: Marseille, Elliot; Kahn, James G.; Pitter, Christian; Bunnell, Rebecca; Epalatai, William; Jawe, Emmanuel; Were, Willy; Mermin, Jonathan

Source: Applied Health Economics and Health Policy, Volume 7, Number 4, 1 December 2009 , pp. 229-243(15)

Publisher: Adis International

The history of antiretrovirals: key discoveries over the past 25 years

Author: De Clercq, Erik

Source: Reviews in Medical Virology, Volume 19, Number 5, September 2009 , pp. 287-299(13)

Publisher: John Wiley & Sons, Ltd.

Antiviral activity, dose-response relationship, and safety of entecavir following 24-week oral dosing in nucleoside-naive Japanese adult patients with chronic hepatitis B: a randomized, double-blind, phase II clinical trial

Authors: Shindo, Michiko; Chayama, Kazuaki; Mochida, Satoshi; Toyota, Joji; Tomita, Eiichi; Kumada, Hiromitsu; Yokosuka, Osamu; Sata, Michio; Hayashi, Norio; Suzuki, Kazuyuki; Okanoue, Takeshi; Tsubouchi, Hirohito; Ishikawa, Hiroki; Seriu, Taku; Omata, Masao

Source: Hepatology International, Volume 3, Number 3, September 2009 , pp. 445-452(8)

Publisher: Springer

Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand

Authors: Chainuvati, Siwaporn; Cheng, Jun; Hou, Jin; Hsu, Chao; Jia, Ji; Komolmit, Piyawat; Kwon, So; Lee, Chang; Li, Hong; Li, Ying; Liu, Chun; Neo, Boon; Peng, Cheng; Tanwandee, Tawesak; Wongcharatrawee, Suchat; Wu, Jaw; Yu, Ming; Zhang, Xin

Source: Hepatology International, Volume 3, Number 3, September 2009 , pp. 453-460(8)

Publisher: Springer

Results of up to 2 years of entecavir vs lamivudine therapy in nucleoside-naïve HBeAg-positive patients with chronic hepatitis B

Authors: Chang, T.-T.; Chao, Y.-C.; Gorbakov, V. V.; Han, K.-h.; Gish, R. G.; de Man, R.; Cheinquer, H.; Bessone, F.; Brett-Smith, H.; Tamez, R.

Source: Journal of Viral Hepatitis, Volume 16, Number 11, November 2009 , pp. 784-789(6)

Publisher: Blackwell Publishing

A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients

Authors: Girard, Pierre-Marie; Cabi, Andr; Michelet, Christian; Verdon, Renaud; Katlama, Christine; Merci, Patrick; Morand-Joubert, Laurence; Ptour, Pascal; Monchecourt, Franoise; Chne, Genevive; Trylesinski, Aldo

Source: Journal of Antimicrobial Chemotherapy, Volume 64, Number 1, 14 July 2009 , pp. 126-134(9)

Publisher: Oxford University Press

Lamivudine/zidovudine/nelfinavir: Liver failure: case report

Source: Reactions, Volume 1, Number 1275, 2009-10-24 , pp. 21-21(1)

Publisher: Adis International

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A